Hepatitis C virus (HCV) replicates in human and chimpanzee hepatocytes. To characterize the nature of HCV and evaluate antiviral agents, the development of an HCV replication system in a cell culture is essential. We developed a cell line derived from human hepatocytes by fusing them with a hepatoblastoma cell line, HepG2, and obtained several clones. When we tested the clones for their ability to support HCV replication by nested RT-PCR, we found 1 clone (IMY-N9) that was more susceptible to HCV replication than HepG2. The negative-strand HCV RNA was detected in IMY-N9 by strand-specific RT-PCR, and viral RNA was identified in culture supernatant during the culture. Hepatitis C virus (HCV) is now recognized as the principal agent in parentally transmitted non-A, non-B hepatitis. HCV is a single-stranded positive-sense RNA virus of about 9,500 nucleotides (nt) that encodes a large polyprotein, 1,2 which is processed into viral structural and nonstructural proteins. Recently, full-length HCV RNA transcripts from HCV cDNAs were shown to be infectious in chimpanzees. 3,4,5 Although our understanding of the molecular biology of HCV has progressed rapidly, little is known about its biological characteristics, because in vivo studies have been limited to the studies performed using chimpanzees that have been infected or transfected with HCV. The development of efficient animal cell culture systems for HCV or readily available animal models are priorities for the study of HCV. HCV replication has been described based on studies of liver tissue and peripheral blood mononuclear cells (PBMC) from infected patients. 6,7 Animal cell culture systems for HCV replication have been developed from human T and B cell lines, 8,9,10 human fetal liver cells, 11,12 and chimpanzee primary hepatocytes. 13 Efficient long-term viral replication, however, has not been reported in any system. HCV replication may be stringently restricted to differentiated hepatocytes, which may have receptors for HCV on their cell surface and specific factors to support viral growth. Recently, a host cellular factor, polypyrimidine-tract-binding protein (PTB), was reported to bind the HCV 3Ј-end, and was thought to be a cis-acting element for HCV replication. 14,15 PTB is also related to the mechanism of HCV translational regulation, 16,17 indicating that several cellular factors may be involved in the mechanism of HCV propagation. We previously reported that HCV replicated efficiently in primary cultured human hepatocytes, 18 and another group also confirmed our findings. 19 However, we still need to develop a more convenient cell-culture system because it is difficult to obtain a constant source of human hepatocytes. In this study, we fused human hepatocytes with a hepatoblastoma cell line, HepG2, and obtained hybrid cell lines. We then tested the ability of the hybrids to support HCV replication by monitoring HCV RNA titers in cultured cells using a real-time detection PCR (RTD-PCR). 20 The results showed that several hybrid cell lines were more suscept...